首页> 外文期刊>Internal medicine. >Acute Kidney Injury due to Renal Sarcoidosis during Etanercept Therapy: A Case Report and Literature Review
【24h】

Acute Kidney Injury due to Renal Sarcoidosis during Etanercept Therapy: A Case Report and Literature Review

机译:依那西普治疗期间肾结节病导致的急性肾脏损伤:一例报道并文献复习

获取原文
获取原文并翻译 | 示例
       

摘要

We herein report a case of renal sarcoidosis presenting as acute kidney injury (AKI) during treatment with etanercept for rheumatoid arthritis. Blood tests showed a high level of angiotensin-converting enzyme and a renal biopsy demonstrated non-caseating granulomatous tubulointerstitial nephritis. The administration of high-dose steroid therapy (1 mg/kg) and discontinuation of etanercept resulted in an improvement in the patient's renal function. Although renal sarcoidosis induced by anti-tumor necrosis factor (TNF) therapy is an extremely rare manifestation, this case suggests that renal sarcoidosis should be considered in the differential diagnosis of AKI in patients receiving anti-TNF therapy, as providing an early diagnosis and treatment is important for preventing irreversible renal impairment.
机译:我们在此报告了在用依那西普治疗类风湿关节炎期间表现为急性肾损伤(AKI)的肾结节病病例。验血显示高水平的血管紧张素转换酶,肾活检显示非干酪性肉芽肿性肾小管间质性肾炎。给予大剂量类固醇疗法(1 mg / kg)和停用依那西普可改善患者的肾功能。尽管由抗肿瘤坏死因子(TNF)治疗诱发的肾结节病是极为罕见的表现,但此病例表明,在接受抗TNF治疗的患者的AKI鉴别诊断中应考虑肾结节病,以提供早期诊断和治疗。对于预防不可逆的肾功能损害非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号